Cryo-EM structures show itraconazole binding and conformational changes in Cdr1, suggesting mechanisms of azole resistance.
Azole resistance in Candida species often results from overexpression of the ABC transporter Cdr1, which expels drugs via ATP-driven conformational changes. Despite its clinical relevance, the structural basis of Cdr1 function has remained elusive. Here, we present four high-resolution cryo-EM structures of Candida glabrata Cdr1 under active turnover with ATP-Mg, itraconazole, and vanadate. Itraconazole is seen to curve deeply into the drug-binding pocket. A deep exploration of the variability within these particle datasets uncovered 80 transient conformations, including two nucleotide-bound states- one closed and one open- that capture, for the first time, the conformational transitions triggered by ATP hydrolysis in both nucleotide-binding and transmembrane domains. At the catalytic site, motion initiates in the C-helix adjacent to the ABC signature motif, retracting 4 A from the gamma-phosphate/vanadate position. This movement, transmitted to nearby TMH-1, opens the drug-binding site via its lateral displacement. A second set of conformations reveals coordinated rearrangements of transmembrane helices that drive substrate extrusion. These findings provide a direct structural and dynamic framework for understanding Cdr1-mediated azole resistance, and, more broadly, illuminate the conserved chemo-mechanical cycle of nucleotide-binding domains across the ABC superfamily, including non-membranous members.
No takes yet. Share an insight, caveat, or question.
Pata et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: